We look at Tesla, Inc.'s Shanghai Megapack factory and how it fuels nonlinear growth. Read more on TSLA stock and why we're ...

Alphabet reported mixed Q4 earnings. Click here to read why GOOG stock is becoming a no-brainer in my view and upgraded to ...

ASML’s strong moat is challenged by potential competitors and geopolitical risks. Read why ASML stock’s premium valuation may ...

The highly anticipated Wiki Finance Expo Hong Kong 2025 is set to take place on March 27, 2025, at The Sky 100 Hong Kong ...

Financial writer discusses how the recent stock dip in Nvidia Corporation is a buying opportunity ahead of Q4 earnings. Click ...

Microsoft Corporation, Oracle Corporation, Alphabet Inc Class A, Amazon.com Inc. Read Charles-Henry Monchau's latest article ...

There are no directors' trades from BetaShares NASDAQ 100 ETF (NDQ). Please use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities. What is the ...

Maze Therapeutics begins Phase 2 trial for kidney disease drug By Investing.com - Feb 07, 2025 SOUTH SAN FRANCISCO – Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical ...

Dropbox numbers look incredibly compelling, but the terminal value component remains an enduring question mark. Click here to read more.

UK is thinking of making households who use streaming services like Netflix and Disney pay a license fee as part of plans to fund the British Broadcasting Corp.

A variety of factors could be at play in this later reporting date. Despite operational challenges in 2022 (there is literally a Wikipedia page dedicated to this failure, entitled “2022 Southwest ...